<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Latest Innovations - Vision Health Portal</title>
    <link rel="stylesheet" href="style.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
    <style>
        .news-grid {
            display: grid;
            grid-template-columns: 1fr;
            gap: 2rem;
            max-width: 900px;
            margin: 0 auto;
        }

        .news-card {
            background: var(--white);
            border-radius: 16px;
            overflow: hidden;
            box-shadow: var(--shadow);
            display: flex;
            flex-direction: column;
            transition: var(--transition);
        }

        .news-card:hover {
            transform: translateY(-5px);
        }

        .news-content {
            padding: 2rem;
        }

        .news-date {
            color: var(--secondary-color);
            font-size: 0.9rem;
            font-weight: bold;
            margin-bottom: 0.5rem;
            display: block;
        }

        .news-title {
            font-size: 1.5rem;
            margin-bottom: 1rem;
            color: var(--text-color);
        }

        .news-summary {
            color: #555;
            margin-bottom: 1.5rem;
        }

        .source-link {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            color: var(--primary-color);
            text-decoration: none;
            font-weight: bold;
        }

        .source-link:hover {
            text-decoration: underline;
        }
    </style>
</head>

<body>

    <div class="floating-container">
        <div class="float-item"><i class="fas fa-dna"></i></div>
        <div class="float-item"><i class="fas fa-microscope"></i></div>
        <div class="float-item"><i class="fas fa-robot"></i></div>
        <div class="float-item"><i class="fas fa-user-md"></i></div>
    </div>

    <header>
        <a href="index.html" class="logo">
            <i class="fas fa-eye"></i> VisionHealth
        </a>
        <nav>
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="tests/index.html">Vision Tests</a></li>
                <li><a href="innovations.html" class="active">Innovations</a></li>
            </ul>
        </nav>
    </header>

    <main class="container">
        <section class="hero">
            <h1>Latest Innovations in Ophthalmology</h1>
            <p>Discover the groundbreaking technologies and treatments from 2024 that are revolutionizing vision care
                and restoring sight.</p>
        </section>

        <div class="news-grid">

            <!-- Item 1: MCO-010 Optogenetic Therapy -->
            <article class="news-card">
                <div class="news-content">
                    <span class="news-date">October 2024</span>
                    <h2 class="news-title">MCO-010: Optogenetic Gene Therapy Restores Vision in Retinitis Pigmentosa
                    </h2>
                    <p class="news-summary">
                        Groundbreaking optogenetic therapy shows up to 50% of patients with severe retinitis pigmentosa
                        gaining three or more lines of visionâ€”without requiring external devices. MCO-010 represents
                        mutation-agnostic treatment with FDA Fast Track designation.
                    </p>
                    <a href="innovations/mco010-optogenetics.html" target="_blank" rel="noopener noreferrer"
                        class="source-link">
                        Read Full Article <i class="fas fa-external-link-alt"></i>
                    </a>
                </div>
            </article>

            <!-- Item 2: AEYE-DS AI Screening -->
            <article class="news-card">
                <div class="news-content">
                    <span class="news-date">April 2024</span>
                    <h2 class="news-title">FDA Authorizes First Portable AI for Diabetic Retinopathy Screening</h2>
                    <p class="news-summary">
                        AEYE-DS becomes the first autonomous AI system approved for diabetic retinopathy detection using
                        handheld cameras, revolutionizing access to screening in underserved communities. This
                        breakthrough enables point-of-care screening in primary care settings.
                    </p>
                    <a href="innovations/aeye-diabetic-screening.html" target="_blank" rel="noopener noreferrer"
                        class="source-link">
                        Read Full Article <i class="fas fa-external-link-alt"></i>
                    </a>
                </div>
            </article>

            <!-- Item 3: ANX007 for Geographic Atrophy -->
            <article class="news-card">
                <div class="news-content">
                    <span class="news-date">2024</span>
                    <h2 class="news-title">ANX007 Achieves 72% Reduction in Vision Loss from Geographic Atrophy</h2>
                    <p class="news-summary">
                        Phase 2 clinical trials demonstrate unprecedented neuroprotection in dry AMD patients. As the
                        first C1q inhibitor for geographic atrophy, ANX007 offers hope for millions facing untreatable
                        vision loss with monthly dosing advancing to Phase 3.
                    </p>
                    <a href="innovations/anx007-ga-treatment.html" target="_blank" rel="noopener noreferrer"
                        class="source-link">
                        Read Full Article <i class="fas fa-external-link-alt"></i>
                    </a>
                </div>
            </article>

            <!-- Item 4: CRISPR Gene Therapy -->
            <article class="news-card">
                <div class="news-content">
                    <span class="news-date">May 2024</span>
                    <h2 class="news-title">CRISPR Gene Editing Successfully Treats Inherited Blindness</h2>
                    <p class="news-summary">
                        The BRILLIANCE trial proves CRISPR-Cas9 can safely restore vision in Leber congenital amaurosis
                        patients, with 79% showing measurable improvements. This first-in-human success validates
                        in-vivo gene editing for treating genetic blindness.
                    </p>
                    <a href="innovations/crispr-lca-therapy.html" target="_blank" rel="noopener noreferrer"
                        class="source-link">
                        Read Full Article <i class="fas fa-external-link-alt"></i>
                    </a>
                </div>
            </article>

        </div>
    </main>

    <footer>
        <div class="footer-content">
            <p>&copy; 2025 Vision Health Portal. All rights reserved.</p>
            <p class="designer-credit">Designed by RITIK DHAGE</p>
        </div>
    </footer>

</body>

</html>